Physician profile
Jacob Kyle Jones
NPI 1588951271
$4,599.75
in general payments reported to CMS, 2019-2025
32 companies · $426 in 2025
The $426 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,284 · 2020: $591 · 2021: $524 · 2022: $376 · 2023: $1,030 · 2024: $369 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,825.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $983.54 | 2019-2023 | |
| Stryker Corporation | $871.77 | 2019-2025 | Prostep, Citrefix, Prostep Mica |
| Medical Device Business Services, INC. | $579.98 | 2020-2021 | |
| Wright Medical Technology, INC. | $339.15 | 2019-2020 | |
| Integra Lifesciences Corporation | $217.53 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Saxum Surgical, INC. | $203.12 | 2023-2024 | |
| Nevro Corp. | $161.32 | 2021-2022 | |
| Smith+Nephew, INC. | $130.85 | 2019-2025 | Renasys Go V2 Home, Stravix, Collagenase Santyl |
| Paratek Pharmaceuticals, INC. | $129.62 | 2022-2023 | Nuzyra |
| Melinta Therapeutics, LLC | $109.93 | 2019 | |
| Novo Nordisk INC | $91.97 | 2019-2025 | Ozempic |
| Inari Medical, INC. | $86.31 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Paragon 28, INC. | $84.59 | 2022 | |
| Polynovo North America LLC | $82.28 | 2024-2025 | Novosorb Btm |
| Ossio INC | $62.09 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $57.85 | 2022-2023 | |
| Averitas Pharma INC. | $51.79 | 2023-2024 | Qutenza |
| Globus Medical, INC. | $44.68 | 2025 | Senza |
| Linvatec Corporation | $39.02 | 2019 | |
| Mimedx Group, INC. | $36.05 | 2025 | |
| Micromed INC | $33.02 | 2022 | |
| Zimmer Biomet Holdings, INC. | $31.17 | 2019 | |
| Osiris Therapeutics INC. | $21.48 | 2019 | |
| Treace Medical Concepts, INC. | $21.16 | 2023 | |
| Horizon Therapeutics Plc | $20.08 | 2023 | Krystexxa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.48 | 2020 | |
| Organogenesis INC. | $18.06 | 2024 | Apligraf |
| Depuy Synthes Sales INC. | $16.91 | 2024 | |
| Amgen INC. | $15.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.71 | 2019 | |
| Amniox Medical, INC. | $14.27 | 2019 | |
| Glaxosmithkline, LLC. | $10.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.